Who Paid My Doc
An Open-label, Single-arm, Single-dose, Prospective, Multicenter Phase 3 Study to Establish the Diagnostic Performance of 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases after Radiation Therapy (the Protocol).
Research payments
$1,259,394
Through program year 2022, $1,259,394 in research payments was reported against An Open-label, Single-arm, Single-dose, Prospective, Multicenter Phase 3 Study to Establish the Diagnostic Performance of 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases after Radiation Therapy (the Protocol)., across 76 payments, paid by Blue Earth Diagnostics Limited.
- Paid by
- Blue Earth Diagnostics Limited
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $1,259,394 | 76 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Arash Kardan Kettering, OH Named on 10 payments
- John Hoffman Salt Lake City, UT Named on 6 payments
- Marcus Ware New Orleans, LA Named on 6 payments
- Jaishri Blakeley Baltimore, MD Named on 5 payments
- James Snyder Detroit, MI Named on 5 payments
- Mariam Aboian Redwood City, CA Named on 5 payments
- Michelle Kim Ann Arbor, MI Named on 5 payments
- Santosh Kesari Santa Monica, CA Named on 4 payments
- Barry Siegel Saint Louis, MO Named on 4 payments
- Erik Sulman Houston, TX Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.